An intelligent tamponade for retinal surgery

Article

When injecting silicone oils with a viscosity of 5000 mPas, which are used frequently, retinal surgeons often reach limits of applicability.

When injecting silicone oils with a viscosity of 5000 mPas, which are used frequently, retinal surgeons often reach limits of applicability. The oils used until now are often too viscous, and therefore hard to apply. Siluron 2000 is a highly pure silicone oil which was designed particularly for small incision surgery.

Siluron 2000 is a mixture of highly purified basic oils with different viscosities and has a viscosity of 2000 mPas. The intelligent combination of mixture ratio and varying viscosities of the basic oils leads to a higher dynamic viscosity of Siluron 2000, according to manufacturer Fluoron. The higher dynamic viscosity enables the newly formulated silicone oil to better resist mechanically applied external force.

The oil is offered in glass syringes (10 mL) which are sterilized by a terminal sterilization process. The product is approved for application in the EU.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.